Medtronic Cardiac Ablation Solutions clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.

1. Notable

   STOP AF First Post-Approval Study

   Primary and study completion moved earlier from Apr 2028 to Oct 2026

   Also in this update: Enrollment closed, study ongoing

   Medtronic Cardiac Ablation Solutions·Not specified· NCT05227053· Registry history of NCT05227053 on ClinicalTrials.gov (opens the registry)

   Sep 23, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.